NanoBiotech SRL
NanoBiotech reported total assets of 1,834 € at the end of the 2025 financial year (annual accounts filed with the NBB on 10 Sep 2026).
The score of NanoBiotech shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
NanoBiotech's annual accounts
| 2025 | |
|---|---|
| Net result | −31,644 € |
| Equity | −26,144 € |
| Cash | 31 € |
| EBITDA | −31,644 € |
| Total assets | 1,834 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 10 Sep 2026
NanoBiotech's financial analysis
- Solvency-1425.4%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of NanoBiotech
NanoBiotech's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1023.651.490
- VAT number
- BE1023651490
- Peppol
- Registered · 0208:1023651490 · as of 11 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 May 2025
- Registered office
- 3590 Diepenbeek
- Latest accounts
- 2025 · filed on 10 Sep 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
NanoBiotech (SRL) has been based in Diepenbeek since 2025, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 31,644 € and equity of −26,144 €; its revenue is not published. Its solvency stands at -1425.4%, below the median of its sector (60.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to NanoBiotech
Companies in the same business, of comparable size and area, outside its group.
- TympRes Research and experimental development on natural sciences and engineering Lovendegem · balance sheet 133,673 €
- Biores Research and experimental development on natural sciences and engineering Oreye · balance sheet 271,675 €
- Dokter Van De Walle Jan Research and experimental development on natural sciences and engineering Boechout · balance sheet 966,727 €
- Dr. J. Bellon Research and experimental development on natural sciences and engineering Buggenhout · balance sheet €3.14m
- Otorino Research and experimental development on natural sciences and engineering Waterloo · balance sheet €1.86m
- Eurimmaux Research and experimental development on natural sciences and engineering Jette · balance sheet 43,305 €
- Rhumat-OS Research and experimental development on natural sciences and engineering Waterloo · balance sheet 658,861 €
- Praktijk Dokter Cooreman Etienne Research and experimental development on natural sciences and engineering Aalst · balance sheet 332,414 €
Frequently asked questions about NanoBiotech
What is the revenue of NanoBiotech?
NanoBiotech files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of NanoBiotech?
In Belgium, the VAT number is the company number prefixed with BE: BE1023651490 for NanoBiotech, if the company is VAT-registered. Its company number (CBE) is 1023.651.490.
Where is the registered office of NanoBiotech?
According to the CBE register, the registered office of NanoBiotech is in 3590 Diepenbeek.
What is the equity of NanoBiotech?
At the close of the 2025 financial year, the equity of NanoBiotech amounts to -26,144 €, a solvency of -1425.4% of total assets.
Who manages NanoBiotech?
The register lists 3 active mandates at NanoBiotech. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of NanoBiotech
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →